Jefferies Financial Group Inc. Purchases New Holdings in Cigna Group $CI

Jefferies Financial Group Inc. bought a new stake in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,840 shares of the health services provider’s stock, valued at approximately $1,610,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter worth about $25,000. Osbon Capital Management LLC bought a new position in Cigna Group in the 2nd quarter worth $26,000. Johnson Financial Group Inc. bought a new position in Cigna Group in the 2nd quarter worth approximately $29,000. Kemnay Advisory Services Inc. bought a new stake in Cigna Group in the 4th quarter valued at $29,000. Finally, Prosperity Bancshares Inc bought a new position in Cigna Group during the fourth quarter valued at about $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI stock opened at $278.89 on Friday. The firm has a market cap of $73.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average price of $283.52 and a 200 day moving average price of $281.39.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. UBS Group increased their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Wells Fargo & Company upped their target price on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Guggenheim lifted their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Barclays raised their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.